Review article: defining remission in ulcerative colitis.

Review article: defining remission in ulcerative colitis.

BACKGROUND: There is no international agreement on scoring systems used to measure disease activity in ulcerative colitis, nor is there a validated definition for disease remission. AIM: To review the principles and components for defining remission in ulcerative colitis and propose a definition th...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Travis, S, Higgins, P, Orchard, T, Van Der Woude, C, Panaccione, R, Bitton, A, O'Morain, C, Panés, J, Sturm, A, Reinisch, W, Kamm, M, D'Haens, G
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registos relacionados

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
Por: Vuitton, L, et al.
Publicado em: (2017)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
Por: Sandborn, W, et al.
Publicado em: (2016)

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
Por: Lichtenstein, G, et al.
Publicado em: (2015)

Review article: maintenance therapy in patients with ulcerative colitis.
Por: Orchard, T, et al.
Publicado em: (2006)

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Por: Travis, S, et al.
Publicado em: (1994)

What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?
Por: Travis, S
Publicado em: (2005)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Por: Jairath, V, et al.
Publicado em: (2017)

Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
Por: Rubin, D, et al.
Publicado em: (2019)

Review article: the management of mild to severe acute ulcerative colitis.
Por: Travis, S
Publicado em: (2004)

Placebo response and remission rates in Ulcerative Colitis clinical trials: Systematic review and meta-analysis
Por: Jairath, V, et al.
Publicado em: (2015)

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
Por: Sandborn, W, et al.
Publicado em: (2015)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
Por: Travis, S
Publicado em: (1997)

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.
Por: Mahmud, N, et al.
Publicado em: (2001)

Review article: the management of severe ulcerative colitis.
Por: Hyde, G, et al.
Publicado em: (1997)

HOW MUCH AGREEMENT IS THERE BETWEEN HISTOLOGICAL, ENDOSCOPIC AND CLINICAL ASSESSMENTS OF REMISSION IN ULCERATIVE COLITIS?
Por: Thomas, S, et al.
Publicado em: (2009)

New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
Por: Walsh, A, et al.
Publicado em: (2018)

Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis.
Por: Guirgis, M, et al.
Publicado em: (2016)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
Por: Travis, S, et al.
Publicado em: (2008)

Predicting outcome in severe ulcerative colitis.
Por: Travis, S
Publicado em: (2004)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
Por: Travis, S, et al.
Publicado em: (2012)

Salicylates for ulcerative colitis--their mode of action.
Por: Travis, S, et al.
Publicado em: (1994)

Therapy of ulcerative colitis: state of the art.
Por: Brain, O, et al.
Publicado em: (2008)

Ulcerative colitis.
Por: Jewell, D
Publicado em: (1975)

Oral methotrexate in ulcerative colitis.
Por: Cummings, JR, et al.
Publicado em: (2005)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Por: Travis, S, et al.
Publicado em: (2013)

The European consensus on ulcerative colitis: new horizons?
Por: Stange, E, et al.
Publicado em: (2008)

Assessing disease activity in patients with ulcerative colitis.
Por: Walsh, A, et al.
Publicado em: (2012)

Diagnostic accuracy of endoscopic trimodal imaging and chromoendoscopy for lesion characterization in ulcerative colitis
Por: Vleugels, JLA, et al.
Publicado em: (2018)

Does it all ADA up? Adalimumab for ulcerative colitis.
Por: Travis, S
Publicado em: (2011)

Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question.
Por: Orchard, T, et al.
Publicado em: (2011)

Predicting outcome in severe ulcerative colitis.
Por: Travis, S, et al.
Publicado em: (1996)

Association between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and outcomes in acute severe ulcerative colitis
Por: Corte, C, et al.
Publicado em: (2015)

Ulcerative colitis in Malaysians
Por: Pailoor, Jayalakshmi, et al.
Publicado em: (1996)

Infliximab for ulcerative colitis.
Por: Simmons, J, et al.
Publicado em: (2002)

Aetiopathogenesis of ulcerative colitis.
Por: Jewell, D
Publicado em: (1987)

Genetics of ulcerative colitis.
Por: Satsangi, J, et al.
Publicado em: (1996)

Pemphigoid and ulcerative colitis.
Por: Barth, J, et al.
Publicado em: (1988)

Azathioprine in ulcerative colitis.
Por: Jewell, D, et al.
Publicado em: (1972)

Ulcerative colitis and sarcoidosis.
Por: Barr, G, et al.
Publicado em: (1986)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
Por: Travis, S, et al.
Publicado em: (2014)